Articles tagged with: simian immunodeficiency virus (SIV)

The capsid inhibitor—a new class to enter clinical trials

published: April, 13, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // African, Caribbean and Black, Social Media, As Prevention , Gay Men, CATIE, Youth, General Health, Treatment Guidelines -including when to start, Women, CATIE - HIV and Hep C Info Resource, Sexual Health, Health, International , Treatment, Media

From CATIE: "This finding suggests that the capsid inhibitor has potential for intermittent dosing in people—perhaps every one or two months."

The capsid inhibitor—a new class to enter clinical trials

Most approved anti-HIV drugs work by interfering with an enzyme and/or protein that is needed by HIV-infected cells to make new viruses. A journey through the cell The capsid is the name given to the proteins that surround HIV’s genetic material. Upon HIV attaching itself to a target cell of the immune system, the virus sends its genetic material (RNA) into the cell. As the genetic material is surrounded by the capsid, it is protected from detection by the cell’s internal sensors. The ca